248 related articles for article (PubMed ID: 21566131)
21. The relationship between fibrogenic TGFβ1 signaling in the joint and cartilage degradation in post-injury osteoarthritis.
Plaas A; Velasco J; Gorski DJ; Li J; Cole A; Christopherson K; Sandy JD
Osteoarthritis Cartilage; 2011 Sep; 19(9):1081-90. PubMed ID: 21624477
[TBL] [Abstract][Full Text] [Related]
22. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
[TBL] [Abstract][Full Text] [Related]
23. ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2.
Park SO; Lee YJ; Seki T; Hong KH; Fliess N; Jiang Z; Park A; Wu X; Kaartinen V; Roman BL; Oh SP
Blood; 2008 Jan; 111(2):633-42. PubMed ID: 17911384
[TBL] [Abstract][Full Text] [Related]
24. A RHAMM mimetic peptide blocks hyaluronan signaling and reduces inflammation and fibrogenesis in excisional skin wounds.
Tolg C; Hamilton SR; Zalinska E; McCulloch L; Amin R; Akentieva N; Winnik F; Savani R; Bagli DJ; Luyt LG; Cowman MK; McCarthy JB; Turley EA
Am J Pathol; 2012 Oct; 181(4):1250-70. PubMed ID: 22889846
[TBL] [Abstract][Full Text] [Related]
25. Deletion of ADAMTS5 does not affect aggrecan or versican degradation but promotes glucose uptake and proteoglycan synthesis in murine adipose derived stromal cells.
Gorski DJ; Xiao W; Li J; Luo W; Lauer M; Kisiday J; Plaas A; Sandy J
Matrix Biol; 2015 Sep; 47():66-84. PubMed ID: 25840345
[TBL] [Abstract][Full Text] [Related]
26. A "traffic control" role for TGFbeta3: orchestrating dermal and epidermal cell motility during wound healing.
Bandyopadhyay B; Fan J; Guan S; Li Y; Chen M; Woodley DT; Li W
J Cell Biol; 2006 Mar; 172(7):1093-105. PubMed ID: 16549496
[TBL] [Abstract][Full Text] [Related]
27. TGFβ1-induced SMAD2/3 and SMAD1/5 phosphorylation are both ALK5-kinase-dependent in primary chondrocytes and mediated by TAK1 kinase activity.
van Caam A; Madej W; Garcia de Vinuesa A; Goumans MJ; Ten Dijke P; Blaney Davidson E; van der Kraan P
Arthritis Res Ther; 2017 May; 19(1):112. PubMed ID: 28569204
[TBL] [Abstract][Full Text] [Related]
28. Nitric oxide induces TIMP-1 expression by activating the transforming growth factor beta-Smad signaling pathway.
Akool el-S; Doller A; Müller R; Gutwein P; Xin C; Huwiler A; Pfeilschifter J; Eberhardt W
J Biol Chem; 2005 Nov; 280(47):39403-16. PubMed ID: 16183640
[TBL] [Abstract][Full Text] [Related]
29. P311 induces the transdifferentiation of epidermal stem cells to myofibroblast-like cells by stimulating transforming growth factor β1 expression.
Li H; Yao Z; He W; Gao H; Bai Y; Yang S; Zhang L; Zhan R; Tan J; Zhou J; Takata M; Wu J; Luo G
Stem Cell Res Ther; 2016 Dec; 7(1):175. PubMed ID: 27906099
[TBL] [Abstract][Full Text] [Related]
30. Inducible lineage-specific deletion of TbetaRII in fibroblasts defines a pivotal regulatory role during adult skin wound healing.
Denton CP; Khan K; Hoyles RK; Shiwen X; Leoni P; Chen Y; Eastwood M; Abraham DJ
J Invest Dermatol; 2009 Jan; 129(1):194-204. PubMed ID: 18563179
[TBL] [Abstract][Full Text] [Related]
31. ALK1 opposes ALK5/Smad3 signaling and expression of extracellular matrix components in human chondrocytes.
Finnson KW; Parker WL; ten Dijke P; Thorikay M; Philip A
J Bone Miner Res; 2008 Jun; 23(6):896-906. PubMed ID: 18333754
[TBL] [Abstract][Full Text] [Related]
32. Fibroblast-specific expression of a kinase-deficient type II transforming growth factor beta (TGFbeta) receptor leads to paradoxical activation of TGFbeta signaling pathways with fibrosis in transgenic mice.
Denton CP; Zheng B; Evans LA; Shi-wen X; Ong VH; Fisher I; Lazaridis K; Abraham DJ; Black CM; de Crombrugghe B
J Biol Chem; 2003 Jul; 278(27):25109-19. PubMed ID: 12707256
[TBL] [Abstract][Full Text] [Related]
33. Knockout of ADAMTS5 does not eliminate cartilage aggrecanase activity but abrogates joint fibrosis and promotes cartilage aggrecan deposition in murine osteoarthritis models.
Li J; Anemaet W; Diaz MA; Buchanan S; Tortorella M; Malfait AM; Mikecz K; Sandy JD; Plaas A
J Orthop Res; 2011 Apr; 29(4):516-22. PubMed ID: 21337391
[TBL] [Abstract][Full Text] [Related]
34. Tumor necrosis factor-alpha regulates transforming growth factor-beta-dependent epithelial-mesenchymal transition by promoting hyaluronan-CD44-moesin interaction.
Takahashi E; Nagano O; Ishimoto T; Yae T; Suzuki Y; Shinoda T; Nakamura S; Niwa S; Ikeda S; Koga H; Tanihara H; Saya H
J Biol Chem; 2010 Feb; 285(6):4060-4073. PubMed ID: 19965872
[TBL] [Abstract][Full Text] [Related]
35. Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling.
Liu N; He S; Ma L; Ponnusamy M; Tang J; Tolbert E; Bayliss G; Zhao TC; Yan H; Zhuang S
PLoS One; 2013; 8(1):e54001. PubMed ID: 23342059
[TBL] [Abstract][Full Text] [Related]
36. Hyaluronan promotes signaling interaction between CD44 and the transforming growth factor beta receptor I in metastatic breast tumor cells.
Bourguignon LY; Singleton PA; Zhu H; Zhou B
J Biol Chem; 2002 Oct; 277(42):39703-12. PubMed ID: 12145287
[TBL] [Abstract][Full Text] [Related]
37. Transforming growth factor-β-mediated CD44/STAT3 signaling contributes to the development of atrial fibrosis and fibrillation.
Chang SH; Yeh YH; Lee JL; Hsu YJ; Kuo CT; Chen WJ
Basic Res Cardiol; 2017 Sep; 112(5):58. PubMed ID: 28871329
[TBL] [Abstract][Full Text] [Related]
38. Endoglin differentially modulates antagonistic transforming growth factor-beta1 and BMP-7 signaling.
Scherner O; Meurer SK; Tihaa L; Gressner AM; Weiskirchen R
J Biol Chem; 2007 May; 282(19):13934-43. PubMed ID: 17376778
[TBL] [Abstract][Full Text] [Related]
39. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling.
Goumans MJ; Valdimarsdottir G; Itoh S; Lebrin F; Larsson J; Mummery C; Karlsson S; ten Dijke P
Mol Cell; 2003 Oct; 12(4):817-28. PubMed ID: 14580334
[TBL] [Abstract][Full Text] [Related]
40. Differential expression of transforming growth factor-beta receptors I and II and activation of Smad 3 in keloid fibroblasts.
Chin GS; Liu W; Peled Z; Lee TY; Steinbrech DS; Hsu M; Longaker MT
Plast Reconstr Surg; 2001 Aug; 108(2):423-9. PubMed ID: 11496185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
